Revive TherapeuticsRVVTF
13F holders, Q1 2024 (March 31)3holders
$0.02avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Revive Therapeutics Ltd. (RVVTF) in their 13F filings. The largest holders were Hilton Capital Management, LLC ($3K), MAI Capital Management ($528) and FineMark National Bank & Trust ($218).
- Company
- Revive Therapeutics Ltd.
- CUSIP
- 761516103
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $11 |
Ownership 3 holders
| Hilton Capital Management, LLC | 0.00% | No change | 125,000 | $3K |
| MAI Capital Management | 0.00% | No change | 25,000 | $528 |
| FineMark National Bank & Trust | 0.00% | No change | 10,345 | $218 |
"% of holder's portfolio" is RVVTF's weight in each manager's 13F, not the share of Revive Therapeutics Ltd. the manager owns.